These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6242422)

  • 1. A comparative study on glucagon effect between McArdle disease and Tarui disease.
    Mineo I; Kono N; Shimizu T; Sumi S; Nonaka K; Tarui S
    Muscle Nerve; 1984 Sep; 7(7):552-9. PubMed ID: 6242422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot-glucagon in the treatment of McArdle's disease.
    Day TJ; Mastaglia FL
    Aust N Z J Med; 1985 Dec; 15(6):748-50. PubMed ID: 3869441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
    Kono N; Mineo I; Sumi S; Shimizu T; Kang J; Nonaka K; Tarui S
    Neurology; 1984 Nov; 34(11):1471-6. PubMed ID: 6593602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral sucrose shortly before exercise on work capacity in McArdle disease.
    Andersen ST; Haller RG; Vissing J
    Arch Neurol; 2008 Jun; 65(6):786-9. PubMed ID: 18541798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemic exercise test: failure to detect partial expression of McArdle's disease.
    Taylor RG; Lieberman JS; Portwood MM
    Muscle Nerve; 1987; 10(6):546-51. PubMed ID: 3476851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease.
    Vissing J; Duno M; Schwartz M; Haller RG
    Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [McArdle's disease: therapeutic use of depot-glucagon].
    Schmid R; Wiethölter H
    Dtsch Med Wochenschr; 1982 Nov; 107(47):1809-11. PubMed ID: 6958445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency?
    Ørngreen MC; Schelhaas HJ; Jeppesen TD; Akman HO; Wevers RA; Andersen ST; ter Laak HJ; van Diggelen OP; DiMauro S; Vissing J
    Neurology; 2008 May; 70(20):1876-82. PubMed ID: 18401027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Exercise-induced muscular weakness, myalgia and contractures. I. A clinical review].
    Mattle H; Jerusalem F
    Schweiz Med Wochenschr; 1977 Apr; 107(13):428-36. PubMed ID: 139680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [McArdle's disease (a familial case)].
    Shevchenko AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):655-9. PubMed ID: 1065164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McArdle disease in a Druze family.
    Sarova-Pinhas I; Sadeh M
    Isr J Med Sci; 1989 Feb; 25(2):64-8. PubMed ID: 2703328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease.
    Mineo I; Kono N; Yamada Y; Hara N; Kiyokawa H; Hamaguchi T; Kawachi M; Yamasaki T; Nakajima H; Kuwajima M
    Muscle Nerve; 1990 Jul; 13(7):618-20. PubMed ID: 2388661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies.
    Vissing J; Vissing SF; MacLean DA; Saltin B; Quistorff B; Haller RG
    J Clin Invest; 1998 Apr; 101(8):1654-60. PubMed ID: 9541495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorders of glycogen and lipid metabolism.
    DiMauro S; Eastwood AB
    Adv Neurol; 1977; 17():123-42. PubMed ID: 142420
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel mutation in the PYGM gene resulting in McArdle disease.
    Rubio JC; Lucia A; Fernández-Cadenas I; Cabello A; Blázquez A; Gámez J; Andreu AL; Martín MA; Arenas J
    Arch Neurol; 2006 Dec; 63(12):1782-4. PubMed ID: 17172620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease.
    Gómez-Gallego F; Santiago C; Morán M; Pérez M; Maté-Muñoz JL; del Valle MF; Rubio JC; Garcia-Consuegra I; Foster C; Andreu IA; Martín MA; Arenas J; Lucia A
    Br J Sports Med; 2008 Feb; 42(2):134-40. PubMed ID: 17616548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonischemic forearm exercise test for McArdle disease.
    Kazemi-Esfarjani P; Skomorowska E; Jensen TD; Haller RG; Vissing J
    Ann Neurol; 2002 Aug; 52(2):153-9. PubMed ID: 12210784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trials of verapamil and dantrolene sodium in McArdle disease.
    Lane RJ; Turnbull DM; Hudgson P; Walton J
    Muscle Nerve; 1984 Sep; 7(7):592-4. PubMed ID: 6399928
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of moderate exercise on insulin sensitivity and substrate metabolism during post-exercise recovery in cirrhosis.
    Petrides AS; Matthews DE; Esser U
    Hepatology; 1997 Oct; 26(4):972-9. PubMed ID: 9328322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year follow-up in a child with McArdle disease: exercise is medicine.
    Pérez M; Foster C; González-Freire M; Arenas J; Lucia A
    Pediatr Neurol; 2008 Feb; 38(2):133-6. PubMed ID: 18206796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.